- REPORT SUMMARY
- TABLE OF CONTENTS
-
Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) of the renal pelvis. These names reflect the type of cell from which the cancer developed. The different types of kidney cancer (such as RCC and TCC) develop in different ways, meaning that the diseases have different long term outcomes, and need to be staged and treated in different ways. RCC is responsible for approximately 80% of primary renal cancers, and TCC accounts the majority of the remainder.
Biological therapies are drugs which are used to kill cancer cells or stop them from growing. Biological therapies are used to try to shrink or control advanced kidney cancer and help people to live longer. You may be given biological therapies for kidney cancer that has already spread, or is at high-risk of coming back after surgery.
This report elaborates on the current development of the Kidney Cancer Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Argos Therapeutics
Immunicum
Roche
Oxford BioMedica
Prometheus Laboratories
Bionomics
Amgen
Wilex
Seattle Genetics
Cerulean Pharma
Ono Pharmaceutical
ArQule
Bayer
Onyx Therapeutics
immatics biotechnologies
Exelixis
Pfizer
Tracon Pharmaceuticals
Active Biotech
Genentech
AVEO Pharmaceuticals
Taiwan Liposome
GlaxoSmithKline
Bristol-Myers Squibb
Abbott Laboratories
Novartis
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Application:
Renal cell carcinoma (RCC)
Transitional cell carcinoma (TCC)
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Kidney Cancer Drugs Industry Overview
-
1.1.1 Kidney Cancer Drugs Market Scope and Market Segments
-
1.1.2 Kidney Cancer Drugs Industry Characteristics
-
1.1.3 Global and China Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Kidney Cancer Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Kidney Cancer Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Angiogenesis Inhibitors
-
1.2.2 mTOR Inhibitors
-
1.2.3 Monoclonal Antibodies
-
1.2.4 Cytokine Immunotherapy (IL-2)
-
1.3 Global Kidney Cancer Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Renal cell carcinoma (RCC)
-
1.3.2 Transitional cell carcinoma (TCC)
-
1.4 Market Analysis by Region
-
1.4.1 North America Kidney Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Kidney Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Kidney Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Kidney Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Kidney Cancer Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Kidney Cancer Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Kidney Cancer Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Kidney Cancer Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Kidney Cancer Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Kidney Cancer Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Kidney Cancer Drugs Industry PEST Analysis
-
2.3 Kidney Cancer Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Kidney Cancer Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Kidney Cancer Drugs Industry
Chapter 3 Global and China Kidney Cancer Drugs Market, by Manufacturer
-
3.1 Global and China Kidney Cancer Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Kidney Cancer Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Kidney Cancer Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Kidney Cancer Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Kidney Cancer Drugs Market Top 3 Players
Chapter 4 Global and China Kidney Cancer Drugs Market, by Type (2017-2028)
-
4.1 Kidney Cancer Drugs Market Trend, by Type
-
4.2 Global Kidney Cancer Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Kidney Cancer Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Kidney Cancer Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Kidney Cancer Drugs Price Trend, by Type (2017-2028)
-
4.3 China Kidney Cancer Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Kidney Cancer Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Kidney Cancer Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Kidney Cancer Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Kidney Cancer Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Kidney Cancer Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Kidney Cancer Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Kidney Cancer Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Kidney Cancer Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Kidney Cancer Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Kidney Cancer Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Kidney Cancer Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Kidney Cancer Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Kidney Cancer Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Kidney Cancer Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Kidney Cancer Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Kidney Cancer Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Kidney Cancer Drugs Market Analysis
-
7.1 North America Kidney Cancer Drugs Market, by Type
-
7.2 North America Kidney Cancer Drugs Market, by Application
-
7.3 North America Kidney Cancer Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Kidney Cancer Drugs Market Analysis
-
8.1 Europe Kidney Cancer Drugs Market, by Type
-
8.2 Europe Kidney Cancer Drugs Market, by Application
-
8.3 Europe Kidney Cancer Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Kidney Cancer Drugs Market Analysis
-
9.1 APAC Kidney Cancer Drugs Market, by Type
-
9.2 APAC Kidney Cancer Drugs Market, by Application
-
9.3 APAC Kidney Cancer Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Kidney Cancer Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Kidney Cancer Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Kidney Cancer Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Kidney Cancer Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Kidney Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Kidney Cancer Drugs Company Profiles
-
11.1 Argos Therapeutics
-
11.1.1 Argos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Argos Therapeutics Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.1.3 Argos Therapeutics Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Immunicum
-
11.2.1 Immunicum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Immunicum Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.2.3 Immunicum Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Roche
-
11.3.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Roche Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.3.3 Roche Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Oxford BioMedica
-
11.4.1 Oxford BioMedica Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Oxford BioMedica Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.4.3 Oxford BioMedica Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Prometheus Laboratories
-
11.5.1 Prometheus Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Prometheus Laboratories Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.5.3 Prometheus Laboratories Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Bionomics
-
11.6.1 Bionomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Bionomics Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.6.3 Bionomics Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Amgen
-
11.7.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Amgen Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.7.3 Amgen Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Wilex
-
11.8.1 Wilex Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Wilex Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.8.3 Wilex Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Seattle Genetics
-
11.9.1 Seattle Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Seattle Genetics Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.9.3 Seattle Genetics Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Cerulean Pharma
-
11.10.1 Cerulean Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Cerulean Pharma Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.10.3 Cerulean Pharma Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Ono Pharmaceutical
-
11.11.1 Ono Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Ono Pharmaceutical Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.11.3 Ono Pharmaceutical Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 ArQule
-
11.12.1 ArQule Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 ArQule Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.12.3 ArQule Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Bayer
-
11.13.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Bayer Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.13.3 Bayer Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Onyx Therapeutics
-
11.14.1 Onyx Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Onyx Therapeutics Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.14.3 Onyx Therapeutics Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 immatics biotechnologies
-
11.15.1 immatics biotechnologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 immatics biotechnologies Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.15.3 immatics biotechnologies Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Exelixis
-
11.16.1 Exelixis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Exelixis Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.16.3 Exelixis Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Pfizer
-
11.17.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Pfizer Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.17.3 Pfizer Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.18 Tracon Pharmaceuticals
-
11.18.1 Tracon Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.18.2 Tracon Pharmaceuticals Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.18.3 Tracon Pharmaceuticals Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.19 Active Biotech
-
11.19.1 Active Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.19.2 Active Biotech Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.19.3 Active Biotech Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.20 Genentech
-
11.20.1 Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.20.2 Genentech Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.20.3 Genentech Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.21 AVEO Pharmaceuticals
-
11.21.1 AVEO Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.21.2 AVEO Pharmaceuticals Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.21.3 AVEO Pharmaceuticals Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.22 Taiwan Liposome
-
11.22.1 Taiwan Liposome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.22.2 Taiwan Liposome Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.22.3 Taiwan Liposome Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.23 GlaxoSmithKline
-
11.23.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.23.2 GlaxoSmithKline Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.23.3 GlaxoSmithKline Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.24 Bristol-Myers Squibb
-
11.24.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.24.2 Bristol-Myers Squibb Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.24.3 Bristol-Myers Squibb Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.25 Abbott Laboratories
-
11.25.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.25.2 Abbott Laboratories Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.25.3 Abbott Laboratories Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.26 Novartis
-
11.26.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.26.2 Novartis Kidney Cancer Drugs Product Profiles, Application and Specification
-
11.26.3 Novartis Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Kidney Cancer Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Kidney Cancer Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Kidney Cancer Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Kidney Cancer Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Kidney Cancer Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Kidney Cancer Drugs Market Size and Growth Rate of Angiogenesis Inhibitors (2017-2028)
-
Figure Global Kidney Cancer Drugs Market Size and Growth Rate of mTOR Inhibitors (2017-2028)
-
Figure Global Kidney Cancer Drugs Market Size and Growth Rate of Monoclonal Antibodies (2017-2028)
-
Figure Global Kidney Cancer Drugs Market Size and Growth Rate of Cytokine Immunotherapy (IL-2) (2017-2028)
-
Figure Global Kidney Cancer Drugs Market Size and Growth Rate of Renal cell carcinoma (RCC) (2017-2028)
-
Figure Global Kidney Cancer Drugs Market Size and Growth Rate of Transitional cell carcinoma (TCC) (2017-2028)
-
Figure North America Kidney Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Kidney Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Kidney Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Kidney Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Kidney Cancer Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Kidney Cancer Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Kidney Cancer Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Kidney Cancer Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Kidney Cancer Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Kidney Cancer Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Kidney Cancer Drugs Market Share, by Manufacturer in 2022
-
Table Global Kidney Cancer Drugs Sales Volume, by Type (2017-2028)
-
Table Global Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Kidney Cancer Drugs Sales Value, by Type (2017-2028)
-
Table Global Kidney Cancer Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Kidney Cancer Drugs Price Trend, by Type (2017-2028)
-
Table China Kidney Cancer Drugs Sales Volume, by Type (2017-2028)
-
Table China Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Kidney Cancer Drugs Sales Value, by Type (2017-2028)
-
Table China Kidney Cancer Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Kidney Cancer Drugs Price Trend, by Type (2017-2028)
-
Table Global Kidney Cancer Drugs Sales Volume, by Application (2017-2028)
-
Table Global Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Kidney Cancer Drugs Sales Value, by Application (2017-2028)
-
Table Global Kidney Cancer Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Kidney Cancer Drugs Sales Value Share, by Application (2017-2028)
-
Table China Kidney Cancer Drugs Sales Volume, by Application (2017-2028)
-
Table China Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Kidney Cancer Drugs Sales Value, by Application (2017-2028)
-
Table China Kidney Cancer Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Kidney Cancer Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Kidney Cancer Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Kidney Cancer Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Kidney Cancer Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Kidney Cancer Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Kidney Cancer Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Kidney Cancer Drugs Sales Volume, by Type (2017-2028)
-
Table North America Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Kidney Cancer Drugs Sales Volume, by Application (2017-2028)
-
Table North America Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Kidney Cancer Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Kidney Cancer Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Kidney Cancer Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Kidney Cancer Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Kidney Cancer Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Kidney Cancer Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Kidney Cancer Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Kidney Cancer Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Kidney Cancer Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Kidney Cancer Drugs Sales Value and Growth Rate (2017-2028)
-
Table Argos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Argos Therapeutics Product Profiles, Application and Specification
-
Table Argos Therapeutics Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Immunicum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Immunicum Product Profiles, Application and Specification
-
Table Immunicum Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Oxford BioMedica Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Oxford BioMedica Product Profiles, Application and Specification
-
Table Oxford BioMedica Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Prometheus Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Prometheus Laboratories Product Profiles, Application and Specification
-
Table Prometheus Laboratories Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bionomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bionomics Product Profiles, Application and Specification
-
Table Bionomics Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Wilex Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Wilex Product Profiles, Application and Specification
-
Table Wilex Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Seattle Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Seattle Genetics Product Profiles, Application and Specification
-
Table Seattle Genetics Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Cerulean Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Cerulean Pharma Product Profiles, Application and Specification
-
Table Cerulean Pharma Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ono Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ono Pharmaceutical Product Profiles, Application and Specification
-
Table Ono Pharmaceutical Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table ArQule Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table ArQule Product Profiles, Application and Specification
-
Table ArQule Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Product Profiles, Application and Specification
-
Table Bayer Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Onyx Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Onyx Therapeutics Product Profiles, Application and Specification
-
Table Onyx Therapeutics Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table immatics biotechnologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table immatics biotechnologies Product Profiles, Application and Specification
-
Table immatics biotechnologies Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Exelixis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Exelixis Product Profiles, Application and Specification
-
Table Exelixis Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Tracon Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Tracon Pharmaceuticals Product Profiles, Application and Specification
-
Table Tracon Pharmaceuticals Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Active Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Active Biotech Product Profiles, Application and Specification
-
Table Active Biotech Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genentech Product Profiles, Application and Specification
-
Table Genentech Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AVEO Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AVEO Pharmaceuticals Product Profiles, Application and Specification
-
Table AVEO Pharmaceuticals Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Taiwan Liposome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Taiwan Liposome Product Profiles, Application and Specification
-
Table Taiwan Liposome Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline Product Profiles, Application and Specification
-
Table GlaxoSmithKline Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Abbott Laboratories Product Profiles, Application and Specification
-
Table Abbott Laboratories Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Kidney Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-